- $589.30m
- $643.05m
- $236.35m
Brief: Orthopediatrics Corp Announces Preliminary Unaudited Net Revenue For Fourth Quarter
Brief: Orthopediatrics Corp Reports Q3 2022 Financial Results
OrthoPediatrics Corp reports results for the quarter ended in September - Earnings Summary
OrthoPediatrics Corp expected to post a loss of 20 cents a share - Earnings Preview
Brief: OrthoPediatrics Corp. Announces Pricing Of $125 Million Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Orthopediatrics Corp. Announces Proposed Offering Of Common Stock And Pre-Funded Warrants
Brief: Orthopediatrics Sees FY Revenue $127 Million To $130 Million
Brief: Orthopediatrics Corp says On June 13, Entered Into Fourth Amendment To Its Fourth Amended And Restated Loan, Security Agreement
OrthoPediatrics declines on $33 mln deal to buy Pega Medical
Brief: Orthopediatrics Corp Announces Deal To Acquire Pega Medical In Deal Valued At $33 Mln
OrthoPediatrics Corp reports results for the quarter ended in March - Earnings Summary
Brief: Orthopediatrics Corp. Reports First Quarter 2022 Financial Results And Increases 2022 Revenue Guidance
OrthoPediatrics Corp expected to post a loss of 37 cents a share - Earnings Preview
OrthoPediatrics Corp reports results for the quarter ended in December - Earnings Summary
Brief: OrthoPediatrics Corp Sees FY Revenue $118 Mln To $121 Mln
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
Brief: OrthoPediatrics Announces Preliminary Unaudited Revenue For The Fourth Quarter & Full-Year 2021
OrthoPediatrics Corp reports results for the quarter ended in September - Earnings Summary
Brief: OrthoPediatrics Corp Reports Q3 2021 Financial Results